Dr. James Kyle Russo II, MD

  • Lafayette, LA
  • Radiation oncologist
NPI1376700591PAC ID2062656051
Medicare services, 2024
20,741
Medicare patients, 2024
982
Part D claims, 2024
738
Publications
8
Hospital affiliations
5
Practice address
120 Rue Louis Xiv, Lafayette, LA 70508
Practice phone
Call (337) 769-7779
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Southern Urology

Lafayette, Louisiana

See all 10 affiliations

Find Dr. Russo's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. James Kyle Russo II is a radiation oncologist in Lafayette, Louisiana

Dr. Russo practices at Southern Urology in Lafayette, Louisiana.

Dr. Russo's NPI, 1376700591, was assigned on May 16, 2008. Dr. Russo graduated from Louisiana State University School of Medicine in Shreveport in 2008. Dr. Russo holds Louisiana license MD.206162.

NPI and contact details
Medicare PAC ID
2062656051
NPI enumeration date
May 16, 2008
NPI status
Active
Accepts Medicare assignment
Yes
Practice phone
(337) 769-7779
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
44
Medical school graduation
2008

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. James Kyle Russo II practices at Southern Urology in Lafayette, Louisiana

Dr. Russo's primary practice is Southern Urology, at 120 Rue Louis Xiv, Lafayette, LA 70508 in Lafayette Parish. The practice phone is (337) 769-7779.

  • Southern Urology
    120 Rue Louis Xiv, Lafayette, LA 70508 · Lafayette ParishPhone(337) 769-7779

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dr. James Kyle Russo II is affiliated with 8 sites of care and 2 medical groups

Dr. Russo's primary practice is Southern Urology in Lafayette, Louisiana. Dr. Russo is also affiliated with Ochsner Lafayette General Medical Center. The medical group on file is Southern Urology. Dmand AI also links Dr. Russo to 4 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

See all 10 affiliations for Dr. Russo

Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Dr. James Kyle Russo II's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Russo practices, 7 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Southern UrologyAvailable with a free account
+7 more sites and 1 medical groupAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Russo practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. James Kyle Russo II is one of 51 radiation oncologists in Louisiana

Radiation oncology is Dr. Russo's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dmand AI has Dr. Russo's licenses on file in 2 states: Louisiana and North Dakota.

Specialties and state licenses

  • Radiation oncology, LouisianaPrimaryLicense MD.206162 · taxonomy 2085R0001X
  • Diagnostic radiology, North DakotaLicense 13254 · taxonomy 2085R0202X

Radiation oncologists near Dr. Russo

Counts of radiation oncologists with a Dmand AI profile, by place and practice. Each opens the list.

51radiation oncologists in Louisiana
5radiation oncologists in Lafayette

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. James Kyle Russo II billed Medicare for 20,741 services in 2024

CMS data shows 20,741 Medicare services from Dr. Russo across 36 procedure codes in 2024, for 982 Medicare patients. Medicare paid $3,609,696 for them. Every service was in an office.

Medicare services, 202420,741
Medicare patients982
Paid by Medicare$3.6M
Procedure codes36

Dr. Russo's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Imaging
2023: 12,0452024: 12,1081%
Other services
2023: 6,7922024: 6,9623%
Lab and pathology
2023: 7082024: 706No change
Office and hospital visits
2023: 7792024: 63419%
Surgery
2023: 3802024: 33113%

Dr. Russo compared with the Louisiana median for radiation oncologists, 2024

  • Dr. Russo
  • Louisiana median
Medicare services
20,741vs 1,72412.0 times
Medicare patients
982vs 1705.8 times
Part D claims
623vs 906.9 times

Medians across 56 radiation oncologists in Louisiana with Dmand AI profiles that report each measure.

Dr. Russo's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Russo

Need commercial claims for Dr. Russo?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Russo and other radiation oncologists in Louisiana.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. James Kyle Russo II treated 982 Medicare patients in 2024, average age 74

CMS counts 982 Medicare patients who saw Dr. Russo in 2024. The largest group is 65 to 74, with 489 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.34, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Russo's median patient age at 71, with 21% women.

Medicare patients, 2024982
Average age74
Average risk score1.34
Also on Medicaid8%

Dr. Russo's Medicare patients by age, 2024

Dr. Russo's Medicare patients by sex, 2024

  • Women24725%
  • Men73575%

Chronic conditions among Dr. Russo's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol75%
  3. Cancer69%
  4. Arthritis41%
  5. Ischemic heart disease37%
  6. Diabetes32%
  7. Chronic kidney disease25%
  8. Anxiety21%

Share of Medicare patients with each condition. A patient can have several.

Dr. Russo's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 71

Patient panel by sex, all payers

  • Women21%
  • Men78%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. James Kyle Russo II wrote 738 Medicare Part D claims in 2024

In 2024, Dr. Russo wrote 738 Medicare Part D claims for 258 patients. 99% of them were for generic drugs. CMS names the drug for 623 of them, across 10 drugs with 11 or more claims each, at $6,566 in total drug cost. In 2023, CMS named 786 claims across 11 drugs.

Part D claims, 2024738
Drugs named by CMS10
Total drug cost$6,566
Part D patients258

Dr. Russo's Part D claims by kind of drug, 2024

  • Generic727 claims99%
  • Brand-name11 claims1%

Dr. Russo's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Russo's Part D claims, 2024

  • Opioids6%41 of 738 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 7862024: 62321%

Drugs named by CMS: 10 in 2024, 11 in 2023.

See all prescribing by Dr. Russo

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

How Dr. James Kyle Russo II takes part in Medicare

Dr. Russo accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Accepts Medicare assignment
Yes

Source: Doctors and Clinicians National Downloadable File (CMS)

For MedTech and pharma teams

Find radiation oncologists like Dr. Russo by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. James Kyle Russo II has 8 publications on record

Dmand AI links 8 papers to Dr. Russo, published from 2011 to 2017. 2011 was the busiest year, with 2. The most frequent topics are Carcinoma, Squamous Cell, Dose Fractionation, Radiation and Lymph Nodes. Dr. Russo has published most often in Head Neck. Dr. Russo's most frequent co-authors are Tarek A. Dufan, MD, Jennifer L. Harper, MD and Nadim Koleilat, MD.

Papers8
Years published2011 to 2017

Dr. Russo's papers by year, 2011 to 2017

Topics Dr. Russo writes about most

  • Carcinoma, Squamous Cell
  • Dose Fractionation, Radiation
  • Lymph Nodes
  • Prostatectomy
  • Prostatic Neoplasms

Dr. Russo's most frequent co-authors

Recent publications by Dr. Russo

See all 8 publications and co-authors

See who Dr. Russo researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Russo works with, so you can find a warm path to the right radiation oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. James Kyle Russo II received $20,150 in industry payments from 2017 to 2025

CMS Open Payments shows 195 general payments to Dr. Russo from 29 drug and device companies from 2017 to 2025. Speaker and faculty fees make up the largest share, 74% of the total. Progenics Pharmaceuticals, Inc. paid the most, $9,020.

General payments to Dr. Russo by program year, 2017 to 2025

General payments to Dr. Russo by kind, 2017 to 2025

$20.2Kin total
  • Speaker and faculty fees$14,83474%
  • Food and beverage$4,63223%
  • Education$3842%
  • Travel and lodging$3001%

Companies that paid Dr. Russo the most, 2017 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Russo

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. James Kyle Russo II graduated from Louisiana State University School of Medicine in Shreveport

Dr. Russo graduated from Louisiana State University School of Medicine in Shreveport in 2008.

  1. Medical schoolLouisiana State University School of Medicine in Shreveport

Source: Dmand AI Professional Profile Data

Sources for Dr. James Kyle Russo II's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Primary practice, affiliations and health systemNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. James Kyle Russo II

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. James Kyle Russo II's NPI number?

Dr. James Kyle Russo II's NPI number is 1376700591. It was assigned on May 16, 2008, and it is active in the NPI Registry.

What kind of doctor is Dr. James Kyle Russo II?

Dr. James Kyle Russo II is a radiation oncologist in Lafayette, Louisiana. The primary specialty in the NPI Registry is Radiation Oncology Physician (taxonomy code 2085R0001X).

Where does Dr. James Kyle Russo II practice?

Dr. Russo practices at 120 Rue Louis Xiv, Lafayette, LA 70508. Dr. Russo's primary practice is Southern Urology in Lafayette, Louisiana. Dmand AI also links Dr. Russo to 4 hospitals, 2 group practices and clinics and 1 medical group.

What is Dr. James Kyle Russo II's office phone number?

The practice phone on file for Dr. Russo is (337) 769-7779.

What is Dr. James Kyle Russo II's medical license number?

Dr. Russo holds Louisiana license MD.206162, one of the licenses on file in 2 states.

Which states has Dr. James Kyle Russo II been licensed in?

Dmand AI has state licenses on file for Dr. Russo in Louisiana and North Dakota.

Which hospitals is Dr. James Kyle Russo II affiliated with?

Dr. Russo is affiliated with Ochsner Lafayette General Medical Center. Dmand AI links Dr. Russo to 4 more hospitals.

What medical group is Dr. James Kyle Russo II part of?

Dr. Russo is linked to Southern Urology. Dmand AI links Dr. Russo to 1 more medical group.

Does Dr. James Kyle Russo II accept Medicare?

Yes. CMS data shows Dr. Russo billed Medicare for 20,741 services in 2024, and Dr. Russo accepts Medicare assignment.

How many Medicare patients does Dr. James Kyle Russo II see?

CMS counts 982 Medicare patients who saw Dr. Russo in 2024, with an average age of 74.

Show 7 more questionsShow fewer questions

What services does Dr. James Kyle Russo II bill to Medicare?

In 2024, Dr. Russo's most billed Medicare services were medicare service (G6015), radiation oncology (77014) and radiation oncology (77336).

Where did Dr. James Kyle Russo II go to medical school?

Dr. Russo graduated from Louisiana State University School of Medicine in Shreveport in 2008.

What drugs does Dr. James Kyle Russo II prescribe most?

In 2024 Medicare Part D data, Dr. Russo's most prescribed drugs by claims were Tamsulosin HCl, Venlafaxine HCl ER and Alfuzosin HCl ER.

Has Dr. James Kyle Russo II received payments from drug or device companies?

CMS Open Payments shows $20,150 in general payments to Dr. Russo from 29 companies from 2017 to 2025. The largest total came from Progenics Pharmaceuticals, Inc.

How long has Dr. James Kyle Russo II been practicing?

Dr. Russo graduated from medical school in 2008, 18 years ago.

Does Dr. James Kyle Russo II do research?

Dmand AI links 8 publications to Dr. Russo, published from 2011 to 2017.

Who does Dr. James Kyle Russo II publish with?

Dr. Russo's most frequent co-authors are Tarek A. Dufan, MD (1 shared paper), Jennifer L. Harper, MD (1 shared paper) and Nadim Koleilat, MD (1 shared paper).

Selling to radiation oncology practices?

See radiation oncologists in Louisiana by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)